Article info

An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants

Authors

  1. Correspondence to Dr Anna Calvert; acalvert{at}sgul.ac.uk
View Full Text

Citation

Calvert A, Andrews N, Barlow S, et al
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants

Publication history

  • Received February 19, 2024
  • Accepted June 14, 2024
  • First published July 8, 2024.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.